The procedure was conducted within the specialized Cardiac Catheterization Laboratory at Joe DiMaggio Children's Hospital as part of an early feasibility clinical trial. The system is currently available at only 10 select medical institutions nationwide, positioning the Florida-based network as the exclusive provider of this technology in the Southeast.

Unlike standard transcatheter valves, the VenusP-Valve is engineered to adapt to diverse patient anatomies. By offering a range of sizes, the device enables clinicians to treat individuals previously deemed ineligible for conventional valve replacements. Dr. Brian Boe, Medical Director of Pediatric Cardiac Interventional Services, noted that the technology facilitates more personalized care for the community. The catheter-based approach avoids the need for open-heart surgery, potentially shortening recovery times while effectively restoring blood flow for both pediatric and adult patients.